Colchicine
Colchicine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Diabete Type 2、Cardiovascular Diseases。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
15 项
已进入 III/IV 期
22 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Montreal Heart Institute
- Herlev and Gentofte Hospital
- Duke University
- Nanjing First Hospital, Nanjing Medical University
- All Natural Medicine Clinic, LLC
- Cairo University
- Niguarda Hospital
- Brigham and Women's Hospital
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
- Major Pharmaceuticals
- A-S Medication Solutions
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
丹麦、美国、中国、Egypt、意大利、Brazil、澳大利亚、加拿大、中国台湾、Singapore、法国、芬兰
正在招募患者的 Colchicine 研究
The COLchicine and Atrial FIBrillation Trial
III 期招募中丹麦NCT05928728PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
III 期招募中美国NCT07232069Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
IV 期招募中中国NCT07349875Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
I 期 / II 期招募中美国NCT04790240Outcomes of Inspiratory Muscle Training in FMF Adolescents
不适用招募中EgyptNCT07129538CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
III 期招募中意大利NCT06158698Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment
II 期招募中美国NCT06855433is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
不适用招募中EgyptNCT07130305Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
III 期招募中BrazilNCT06930885The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
III 期招募中澳大利亚中国NCT06763055Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
III 期招募中加拿大NCT06440694Colchicine in Chronic Limb-Threatening Ischemia
III 期招募中中国台湾NCT07536373Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes
II 期招募中SingaporeNCT07837934Colchicine Versus Placebo in Acute Myocarditis Patients
III 期招募中法国NCT05855746Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients
不适用招募中中国NCT07064109COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
III 期招募中澳大利亚加拿大丹麦芬兰NCT05633810Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
III 期招募中美国澳大利亚比利时BrazilNCT04774159Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome
II 期招募中ChileNCT05472337ACT-GLOBAL Adaptive Platform Trial for Stroke
III 期招募中澳大利亚加拿大NCT06352632A Randomized Multicenter Study for Isolated Skin Vasculitis
II 期招募中美国加拿大日本NCT02939573Colchicine's Effect on Inflammatory Markers
IV 期招募中美国NCT07287345The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
IV 期招募中美国NCT05618353Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
II 期招募中中国NCT07026994The Effect of ColcHicine on the Incidence of Knee or Hip Replacements
III 期招募中荷兰NCT06578182
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。